Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer (DEREDIA)

March 12, 2026 updated by: Centre Oscar Lambret

Determinants of the Consultation Delay in Cancers of the Upper Aero Digestive Tract

This study aims to determine the impact of sociocognitive and emotional factors on the time of the initial consult

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

identify wich sociocognitive factors influence the delay to go to a doctor after the emergence of first symptoms

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Boulogne-sur-Mer, France, 62 231
        • Centre Hospitalier
      • Lille, France, 59 020
        • Oscar Lambret Center
      • Lille, France, 59 037
        • Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
      • Lille, France, 59 042
        • La Louviere Hospital
      • Maubeuge, France, 59 600
        • Gray Center
      • Saint-Martin-Boulogne, France, 62280
        • Centre Médical Spécialisé du Littoral

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age ≥ 18 years
  • oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
  • non treated cancer
  • patient informed of his diagnosis
  • speak fluent french
  • patient covered by health insurance
  • signed informed consent

Inclusion Criteria for "interviewed " patients :

  • no speech troubles
  • patient consents being recorded

Exclusion Criteria:

  • history of cancer
  • psychological history
  • patient under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: questionnaires
4 questionnaires to answer at baseline 45 minutes approx.
Behavioral: questionnaires
questionnaires to answer at baseline 45 minutes
Experimental: interview
semi directive interview 105 patients
Behavioral: questionnaires
questionnaires to answer at baseline 45 minutes
Behavioral: interview
25 minutes of semi directive interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time of first consultation
Time Frame: baseline
median time between date of symptoms appearance and date of first consultation
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
identify variables associated with time of consultation
Time Frame: baseline
medical data : medical history, symptoms, entry into care pathway sociodemographic and emotional indicators
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Oscar Lambret

Investigators

  • Study Director: Veronique CHRISTOPHE, MDPhD, Lille 3 University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2012

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

July 19, 2012

First Submitted That Met QC Criteria

July 19, 2012

First Posted (Estimated)

July 23, 2012

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DEREDIA - 1110
  • 2012-A00005-38 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Aerodigestive Tract Cancer

Clinical Trials on questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe